Lasting Effect Consumer Pharma Overview
Lasting Effect developed a Buccal extended controlled release delivery system. The system is a platform enables topical effect or systemic absorption of active ingredients through transmucosal and sublingual routes, Bypassing first-pass metabolism and offers a greater bioavailability, while maintaining user’s compliance during both wakefulness and sleeping hours. The technology based on patented extended controlled release mechanism, combined with selected taste compounds that generates saliva. Lasting Effect drug delivery system is a platform enables topical effect or systemic absorption of active ingredients through transmucosal route, offers a greater bioavailability, while maintaining user’s compliance during both wakefulness and sleeping hours. The technology based on patented extended controlled release system, combined with selected taste compounds that generates saliva. The saliva dissolves the tablet and the active material loaded on it. The technology enables to load and dissolve a wide range of active materials, including lipophile hydrophobic materials. The platform tablet adhered to the mucosa in the oral cavity, laniary dissolving for up to 8 hours while screening bitter tastes of the active materials. All the inactive materials of the platform are GRAS. Products: 1. Buccal tablet for Xerostomia and Halitosis. Regulation as dietary supplement. Ready to market. 2. Tablet loaded with CBD for Gingivitis - gum inflammation, treatment. The product is in a clinical stage. The tablet loaded with CBD shown a powerful anti-inflammatory effect, inhibiting between 93-96% of Gingivitis causing bacteria's. 3. In development - tablet for Parkinson and cognitive impairments treatment. Unique formulation of antiparkinsonian drugs, which is loaded into the tablet and releases continuously the APIs in the oral cavity, enabling to provide a continues dopaminergic stimulation. Partners: Maccabi HealthCare, Padagis Pharma, OwerCrowd, Kobi Zaharia, Ariel Malik.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
Funding
| Total funding | $1.85M |
| Last funding | $850K |
| Stage | Pre-Seed |
| Rounds | 2 |
| Investors | 3 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | lasting-effect.com |
Locations
Be'er Sheva, Israel
Photos & Videos
3 item(s)
Lasting Effect Consumer Pharma Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
—Tags (6)
healthcareparkinsondrug-deliverymedical-cannabispharma-companiespharmaceuticalsGeographic Markets
AsiaNorth AmericaEuropeSouth AmericaLasting Effect Consumer Pharma Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
Lasting Effect Consumer Pharma Lifecycle
Cumulative Funding Raised Over Time
All Events
Lasting Effect Consumer Pharma News
0 articlesNo news articles.
Lasting Effect Consumer Pharma Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 7 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 6 classification IDs that could be used for matching.
Lasting Effect Consumer Pharma Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 80/100 |
| Missing | sector, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516174455 |
| Phone | 0524040636 |
| Creator | Igal Pikovsky |
| Creator email | igal@lasting-effect.com |
| Last update | 2023-08-21T00:00:00.000Z |
| Created | 2023-08-21T00:00:00.000Z |
| Claimed | Yes |